Please Scroll Down to See Forums Below 
here's some info regarding bromo for weightloss but being potentiated by serotonin agonists...which raises the question, what's a cheap, easily obtainable serrotonin agonist?
taken from http://www.pslgroup.com/dg/95e6.htm
"In one study, "Dopaminergic D1/D2 Synergism Reverses Obesity and Lipid Disorders in the Leptin-Deficient ob/ob Mouse," by E. Tozzo, et. al., Ergo Science researchers established that stimulation of two dopaminergic receptors produced a significant (between 50 and 60%) reduction in food intake, dramatic weight loss and a decrease in fat stores of 22-32% with no significant decrease in lean body (muscle) mass. This approach also improved glycemic control, reducing glucose 57% and insulin 50%, respectively. These effects were accomplished without the administration of exogenous leptin. In a second study, Ergo researchers found that timed administration of a dopamine agonist and a serotonin agonist reduced body fat 30-75% and body weight gain 40-60%. In this study, lean body mass was increased 5-17% confirming that the two drug regimen was able to reduce weight by selectively reducing body fat. Again, these reductions were accomplished without the administration of leptin. The selective reduction in body fat and preservation of lean body mass has significant implications for the treatment of human obesity as improvement in the lean-to-fat ratio is thought to be closely associated with a reduction in the cardiovascular risk factors resulting from chronic obesity."
taken from http://www.pslgroup.com/dg/95e6.htm
"In one study, "Dopaminergic D1/D2 Synergism Reverses Obesity and Lipid Disorders in the Leptin-Deficient ob/ob Mouse," by E. Tozzo, et. al., Ergo Science researchers established that stimulation of two dopaminergic receptors produced a significant (between 50 and 60%) reduction in food intake, dramatic weight loss and a decrease in fat stores of 22-32% with no significant decrease in lean body (muscle) mass. This approach also improved glycemic control, reducing glucose 57% and insulin 50%, respectively. These effects were accomplished without the administration of exogenous leptin. In a second study, Ergo researchers found that timed administration of a dopamine agonist and a serotonin agonist reduced body fat 30-75% and body weight gain 40-60%. In this study, lean body mass was increased 5-17% confirming that the two drug regimen was able to reduce weight by selectively reducing body fat. Again, these reductions were accomplished without the administration of leptin. The selective reduction in body fat and preservation of lean body mass has significant implications for the treatment of human obesity as improvement in the lean-to-fat ratio is thought to be closely associated with a reduction in the cardiovascular risk factors resulting from chronic obesity."
